Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Thomas Tu, Stephan Urban
Current Opinion in Virology (2018) Vol. 30, pp. 68-79
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico
Gut (2021) Vol. 70, Iss. 9, pp. 1782-1794
Open Access | Times Cited: 174
Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies
Pietro Lampertico, Dominique Roulot, Heiner Wedemeyer
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1422-1430
Closed Access | Times Cited: 79
The evolution and clinical impact of hepatitis B virus genome diversity
Peter Revill, Thomas Tu, Hans Netter, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 618-634
Closed Access | Times Cited: 136
Hepatitis B Virus Entry into Cells
Charline Herrscher, Philippe Roingeard, Emmanuelle Blanchard
Cells (2020) Vol. 9, Iss. 6, pp. 1486-1486
Open Access | Times Cited: 127
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
Mala K. Maini, Alice R. Burton
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 662-675
Open Access | Times Cited: 111
Relevance of HBx for Hepatitis B Virus-Associated Pathogenesis
Anja Schollmeier, Mirco Glitscher, Eberhard Hildt
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4964-4964
Open Access | Times Cited: 34
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 9
Cellular Genomic Sites of Hepatitis B Virus DNA Integration
Magdalena A. Budzinska, Nicholas Shackel, Stephan Urban, et al.
Genes (2018) Vol. 9, Iss. 7, pp. 365-365
Open Access | Times Cited: 72
Host Genetic Determinants of Hepatitis B Virus Infection
Zhenhua Zhang, Changtai Wang, Zhongping Liu, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 65
De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
Thomas Tu, Benno Zehnder, Bingqian Qu, et al.
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100195-100195
Open Access | Times Cited: 51
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
Zhenfeng Zhang, Stephan Urban
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 686-699
Open Access | Times Cited: 50
Viral hepatitis: Milestones, unresolved issues, and future goals
Pietro Torre, Andrea Aglitti, Mario Masarone, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 28, pp. 4603-4638
Open Access | Times Cited: 42
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure
David Yardeni, Kyong–Mi Chang, Marc G. Ghany
Gastroenterology (2022) Vol. 164, Iss. 1, pp. 42-60.e6
Open Access | Times Cited: 35
Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers
Kosaku Kitagawa, Kwang Su Kim, Masashi Iwamoto, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 3, pp. e1011238-e1011238
Open Access | Times Cited: 7
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
Kento Fukano, Senko Tsukuda, Mizuki Oshima, et al.
Frontiers in Microbiology (2019) Vol. 9
Open Access | Times Cited: 48
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals
Dieter Glebe, Nora Goldmann, Chris Lauber, et al.
Antiviral Research (2020) Vol. 186, pp. 104973-104973
Open Access | Times Cited: 48
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers
Verena Hehle, Maxime Beretta, Maryline Bourgine, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 10
Open Access | Times Cited: 46
The Hepatitis B Virus Envelope Proteins: Molecular Gymnastics Throughout the Viral Life Cycle
Stefan Seitz, Jelena Habjanič, Anne K. Schütz, et al.
Annual Review of Virology (2020) Vol. 7, Iss. 1, pp. 263-288
Closed Access | Times Cited: 42
The Hepatitis B Virus Nucleocapsid—Dynamic Compartment for Infectious Virus Production and New Antiviral Target
Matthias Niklasch, Peter Jan Zimmermann, Michael Nassal
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1577-1577
Open Access | Times Cited: 38
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life
Tarik Asselah, Dimitri Loureiro, Frédéric Le Gal, et al.
Liver International (2021) Vol. 41, Iss. 7, pp. 1509-1517
Closed Access | Times Cited: 37
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Cheng‐Jian Xu, Kerstin Port, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 7, pp. 597-606
Open Access | Times Cited: 13
Hepatitis D infection: from initial discovery to current investigational therapies
Ben L. Da, Theo Heller, Christopher Koh
Gastroenterology report (2019) Vol. 7, Iss. 4, pp. 231-245
Open Access | Times Cited: 42
Endpoints and New Options for Treatment of Chronic Hepatitis D
Anna S. Lok, Francesco Negro, Tarik Asselah, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3479-3485
Open Access | Times Cited: 31
Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP
Monique D. Appelman, Jochen M. Wettengel, Ulrike Protzer, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1866, Iss. 8, pp. 158960-158960
Open Access | Times Cited: 29
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
Elisabetta Degasperi, Maria Paola Anolli, Pietro Lampertico
Journal of Viral Hepatitis (2023) Vol. 30, Iss. S1, pp. 27-33
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top